Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 370 | 120 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 257 |
| TOTAL | $N/A | $462 | $245 | $N/A | $257 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 69,389 | 68,573 | 0 | 0 |
| TOTAL | $N/A | $69,389 | $68,573 | $N/A | $N/A |
| Total Assets | $N/A | $69,850 | $68,818 | $N/A | $257 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 350 | N/A | N/A | 193 |
| Accrued Expenses | N/A | 114 | 48 | N/A | 74 |
| TOTAL | $N/A | $464 | $48 | $N/A | $267 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 69,389 | 68,573 | 0 | 0 |
| TOTAL | $N/A | $69,389 | $68,573 | $N/A | $N/A |
| Total Liabilities | $N/A | $69,852 | $68,621 | $N/A | $267 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,941 | 8,941 | 8,941 | 8,941 | 8,941 |
| Retained earnings | N/A | -2 | 197 | N/A | -10 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -25 |
| TOTAL | $N/A | $-2 | $198 | $N/A | $-10 |
| Total Liabilities And Equity | $0 | $69,850 | $68,818 | $0 | $257 |